Medication info
Itax Cimetidine Tablet (Cimetidine)

Itax Cimetidine Tablet (Cimetidine)

Prescription medicationTabletOral
Ingredient · strength
Cimetidine›200mg / 1 tablet
Manufacturer / importer
Teragen Itax Co., Ltd.
Appearance
Pale green round film-coated tablet
Packaging
For domestic use - 1000 tablets/bottle, for export - 100 tablets/box [10 tablets/PTP × 10]
Approval status
Active

MFDS item code 200402420 · Notified 2004.07.09 · Insurance code 698500200

Summary

Main use
Treatment of acid-related disorders (ulcers, reflux esophagitis, etc.) and improvement of gastric mucosal lesions in gastritis
Who takes it
Adults · Children
Adult dose
Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally four times daily (after meals and at bedtime). The dose may be increased to 400 mg four times daily (after meals and at bedtime; total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions—acute gastritis and acute exacerbation of chronic gastritis—administer 200 mg twice daily or 400 mg once daily. Antacids may be administered as needed to relieve pain. The dose may be increased depending on the patient; in this case, increase the number of administrations rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this drug twice daily, every 12 hours. If necessary based on the patient's symptoms, the frequency may be increased to three times daily, every 8 hours, or more often, but use caution. In patients with severe renal impairment, the drug may accumulate in the body; therefore, reduce the frequency of administration to a minimum based on the patient's response. Hemodialysis lowers serum cimetidine levels. After hemodialysis is completed, administer the drug again according to the schedule. Adjust the dose as appropriate according to age and symptoms.
Child dose
Children: Administer 20 〜 40 mg/kg/day orally in divided doses.

Ingredients

Manufacturer
Teragen Itax Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, reflux esophagitis, etc.) and improvement of gastric mucosal lesions in gastritis

  • Gastric and duodenal ulcers
  • gastroesophageal reflux disease
  • recurrent ulcers
  • anastomotic ulcers
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosions
  • bleeding
  • erythema
  • edema
  • acute gastritis
  • exacerbation of chronic gastritis
View approved original text

This medication is used for various gastrointestinal diseases such as gastric and duodenal ulcers, gastroesophageal reflux disease, recurrent ulcers, anastomotic ulcers, and Zollinger-Ellison syndrome. It is also effective in improving gastric mucosal lesions such as erosions, bleeding, erythema, and edema that occur during exacerbations of acute and chronic gastritis. It helps alleviate symptoms of these conditions and protects the gastric mucosa, aiding in rapid recovery. Therefore, this drug is a reliable choice for treating gastric mucosal diseases and improving symptoms.

How to take

Adult dose

Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally four times daily (after meals and at bedtime). The dose may be increased to 400 mg four times daily (after meals and at bedtime; total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions—acute gastritis and acute exacerbation of chronic gastritis—administer 200 mg twice daily or 400 mg once daily. Antacids may be administered as needed to relieve pain. The dose may be increased depending on the patient; in this case, increase the number of administrations rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this drug twice daily, every 12 hours. If necessary based on the patient's symptoms, the frequency may be increased to three times daily, every 8 hours, or more often, but use caution. In patients with severe renal impairment, the drug may accumulate in the body; therefore, reduce the frequency of administration to a minimum based on the patient's response. Hemodialysis lowers serum cimetidine levels. After hemodialysis is completed, administer the drug again according to the schedule. Adjust the dose as appropriate according to age and symptoms.

Child dose

Children: Administer 20 〜 40 mg/kg/day orally in divided doses.

Precautions

This medication should be used with great caution when using glass ampule injections due to the risk of glass fragments entering the solution, especially in children and the elderly. It should not be administered to patients with allergies or a history of hypersensitivity to cimetidine or other components of this medication, to patients at risk for specific arrhythmias, and to those with genetic issues like lactose intolerance. Patients with kidney or liver function problems, elderly patients, children under 19 years, and patients undergoing hemodialysis may require dosage adjustment or changes in administration intervals, and caution is needed as symptoms of gastric cancer may be masked. This medication can cause various adverse reactions affecting the blood, liver, kidneys, skin, and nervous system, so immediate consultation with medical personnel is essential when symptoms occur. During treatment, it is important to carefully monitor the progression of the disease, change treatment methods if ineffective, and perform regular blood, liver, and kidney function tests. This medication can interact with many other drugs; therefore, if other medications are being taken, it is imperative to inform the medical staff, and dosage adjustments or temporary cessation may be necessary. Pregnant or breastfeeding women should consult with medical personnel before administration to carefully consider the potential impact on the fetus or newborn. Safety has not been sufficiently confirmed for children, so it should only be administered in special cases, and dosage may need to be reduced or intervals extended in the elderly due to decreased kidney function. In case of overdose, serious side effects such as respiratory depression may occur, so precise adherence to the prescribed dosage as directed by healthcare providers is essential, and immediate medical attention is required if side effects arise. If used in injection form, rapid intravenous administration may induce arrhythmias or hypotension, so it should be administered slowly. Store in a safe place out of reach of children and do not transfer to other containers to maintain the safety and quality of the medication.

Side effects

  • Leukopenia
  • neutropenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • general malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
Show 51 more
  • fever
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
  • elevated ALT
  • liver dysfunction
  • perivascular peritoneal fibrosis
  • interstitial seizures
  • acute kidney failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • shock
  • anaphylactic-like reaction
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • galactorrhea
  • increased leukorrhea
  • erectile dysfunction
  • abdominal distension
  • constipation
  • diarrhea
  • headache
  • dizziness
  • seizures
  • limb paresthesia
  • stiffness
  • drowsiness
  • hypochondriacal symptoms
  • altered consciousness
  • delirium
  • bradycardia
  • tachycardia
  • palpitations
  • heart block
  • skin/mucosal syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema
  • fatigue
  • generalized heat sensation
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering, ideally at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication and prevents deterioration.

Appearance and packaging

Appearance

Pale green round film-coated tablet

Package unit

For domestic use - 1000 tablets/bottle, for export - 100 tablets/box [10 tablets/PTP × 10]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.